Followers

April 24, 2024

Lupin receives EIR from US FDA for its Aurangabad manufacturing facility

The inspection was conducted from March 6-15, 2024. The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/zPMeUQn

No comments:

Post a Comment